Tesamorelin Peptide Vial Lyophilisate For Lab Research

What is Tesamorelin?

Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) consisting of the full 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid group attached to stabilise the molecule. This modification enhances its resistance to enzymatic degradation while preserving full biological activity at the GHRH receptor. Tesamorelin is one of the most potent and well-characterised GHRH analogues used in endocrinology and metabolic research.

Key Research Areas

• Growth Hormone Stimulation — Potent GHRH receptor agonist studied for its ability to stimulate pulsatile GH secretion from the anterior pituitary
• Visceral Adiposity Research — Investigated for its effects on visceral fat reduction through GH-mediated lipolysis in metabolic models
• IGF-1 Axis — Studied for downstream effects on insulin-like growth factor-1 (IGF-1) production and anabolic signalling
• Cognitive & Neuroprotective Research — Explored for potential effects on cognitive function and brain metabolism via GH/IGF-1 pathways
• Metabolic Syndrome Models — Investigated for its role in improving lipid profiles and body composition in preclinical metabolic research

Product Details

• Quantity: 5mg per vial
• Form: Lyophilisate (lyophilized powder)
• Intended for research purposes only